February 2, 2015
Drugs that can cure hepatitis C virus (HCV) are on the market in some
countries. But these drugs are unaffordable for most of the 150 million
people living with hepatitis C globally --90% of whom live in
resource-limited settings. Activism to overcome pricing and other
barriers to treatment is urgently needed.
TAG is pleased to release Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries
This guide presents key strategies through real-world case studies, and
shows how strategies used to combat the AIDS epidemic can be—and have
been—adapted to increase HCV treatment access.
We hope you find this document useful in your global treatment advocacy work. Please share widely with relevant stakeholders.
Section One: Laying the Groundwork through Community Organizing
Section Two: Overcoming the Cost Barriers to HCV Treatment Access
Section Three: Collaborating with Researchers to Build Your Case for HCV Treatment Access
Director, International Hepatitis/HIV Policy & Advocacy
ABOUT TAG’S HEPATITIS/HIV PROJECT
TAG’s Hepatitis/HIV Project draws from the core values and history of
HIV activism, while incorporating hepatitis C–specific information into
strategies targeting different constituencies, regions, and countries.
The Hepatitis/HIV Project focuses on optimizing quality of, and
broadening access to, HCV care and treatment for communities and
individuals by continuing its domestic and international work with other
activists, regulatory agencies, pharmaceutical companies, clinicians,
and the patient community
Labels: Activist strategies, Treatment Action Group (TAG)